F.D.A. studies show the shot strongly protects against severe illness and may reduce spread of the virus. But the drugmaker has fallen short of initial production goals.
Tag: Johnson & Johnson
F.D.A. Analyses Find Johnson & Johnson Vaccine Works Well
F.D.A. studies show the shot strongly protects against severe illness and may reduce spread of the virus. But the drugmaker has fallen short of initial production goals.
South Africa Halts Coronavirus Vaccine Rollout Because of New Variant
A finding that the AstraZeneca-Oxford vaccine had little effect on a fast-spreading coronavirus variant was baleful news for South Africa and other countries counting on the shot.
How New Vaccine News Gives Hope for Spring, if Enough People Get the Shots
New data from several vaccine trials offer positive signs, but many public health experts say emerging variants mean the next few months will be a race against the virus.
How the Out-of-Control Pandemic Is Speeding the Testing of Vaccines
The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.
Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine
In Boston and in the Netherlands, scientists are racing to build a vaccine against the virus strangling the world.
Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups
New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.
More Coronavirus Vaccines and Treatments Move Toward Human Trials
Just three months after the start of the coronavirus pandemic, several biotech companies are beginning trials of promising vaccines and treatments.
Researchers Are Racing to Make a Coronavirus Vaccine. Will It Help?
New technology and better coordination have sped up development. But a coronavirus vaccine is still months — and most likely years — away.
In Congo, a New Plan to Fight Ebola Follows a Government Power Struggle
After the resignation of the country’s health minister, the president will take over the response to the epidemic and distribute a new vaccine.